FDA slammed for perpetuating “confusion and gray area” in CBD supplement regulation

The US food and drug agency holds its ground that risks run too high to allow the ingredient to be openly marketed

Related Articles

Court room.

NUTRITION & HEALTH NEWS

08 Dec 2023 --- This week in nutrition news, Gencor’s Levagen+ nutraceutical ingredient was found to reduce seasonal allergy symptoms. At the same time, the... Read More

CBD regulatory framework proposal to the US Congress

NUTRITION & HEALTH NEWS

08 Dec 2023 --- The One Hemp coalition advised the US Congress and the FDA this week on a policy solution to create a regulatory framework for CBD or hemp-derived... Read More

Pregnant woman looking at prenatal supplements.

NUTRITION & HEALTH NEWS

08 Dec 2023 --- International researchers suggest that over-the-counter supplements can reduce vitamin insufficiencies in women during preconception, pregnancy and... Read More

Diabetes technology

NUTRITION & HEALTH NEWS

06 Dec 2023 ---  The landscape of diabetes prevention is evolving, with advancements in technology playing a pivotal role in shaping new solutions and approaches.... Read More

Green Bridge Gateway

NUTRITION & HEALTH NEWS

05 Dec 2023 --- The Association for the Cannabinoid Industry (ACI) has formed the Green Bridge Gateway, composed of the Global Regulatory Services (GRS), ADSL, Shweed... Read More

trans